Literature DB >> 17944158

Depression in primary caregivers of patients listed for liver or kidney transplantation.

Ahmed Bolkhir1, Marci M Loiselle, Donna M Evon, Paul H Hayashi.   

Abstract

BACKGROUND: No studies have examined depression in primary caregivers of adult patients listed for liver or kidney transplantation.
OBJECTIVE: To determine the prevalence of depression among primary caregivers of patients listed for liver or kidney transplantation and to compare these 2 groups.
DESIGN: A cross-sectional survey was conducted. The Center for Epidemiologic Studies Depression Scale and a demographic questionnaire were sent out and returned by mail.
RESULTS: Of 72 eligible primary caregivers, 42 (58%) participated; the participation rate was similar for caregivers of kidney and liver failure patients (21/32 [66%)] vs 21/40 [53%], P = .3). Mean caregiver age was 54.7 +/- 13.6 years. Twenty-three caregivers (54.8%) were spouses, 15 (35.7%) were first-degree relatives, and 26 (62%) were women. Median depression scale score was 5.5 (0-36). Three (7%), 2 (5%), and 3 (7%) participants reported mild, moderate, and severe depression, respectively. Median Center for Epidemiologic Studies Depression Scale score was higher among caregivers of liver versus kidney patients, but the difference was not statistically significant (9 vs 4, P = .2). Depression scale scores did not correlate with age, sex, time listed, or nature or length of relationship with the patient. The prevalence of depression in primary caregivers was 19%; of these caregivers, one third may have had severe depression.
CONCLUSIONS: The prevalence of moderate to severe depression in primary caregivers of liver and kidney transplant candidates is significant. The impact of depression on caregivers as well as patients, both before and after transplantation, deserves study. Screening for depression in caregivers could lead to clinical interventions that benefit caregivers and indirectly improve patient outcomes.

Entities:  

Mesh:

Year:  2007        PMID: 17944158     DOI: 10.1177/152692480701700306

Source DB:  PubMed          Journal:  Prog Transplant        ISSN: 1526-9248            Impact factor:   1.065


  6 in total

1.  Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study.

Authors:  Lissi Hansen; Karen S Lyons; Nathan F Dieckmann; Michael F Chang; Shirin Hiatt; Emma Solanki; Christopher S Lee
Journal:  Res Nurs Health       Date:  2017-06-30       Impact factor: 2.228

2.  The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers.

Authors:  Jasmohan S Bajaj; James B Wade; Douglas P Gibson; Douglas M Heuman; Leroy R Thacker; Richard K Sterling; R Todd Stravitz; Velimir Luketic; Michael Fuchs; Melanie B White; Debulon E Bell; HoChong Gilles; Katherine Morton; Nicole Noble; Puneet Puri; Arun J Sanyal
Journal:  Am J Gastroenterol       Date:  2011-05-10       Impact factor: 10.864

3.  Predictors and outcomes of health-related quality of life in caregivers of cardiothoracic transplant recipients.

Authors:  L Myaskovsky; D M Posluszny; R Schulz; A F DiMartini; G E Switzer; A DeVito Dabbs; M L McNulty; R L Kormos; Y Toyoda; M A Dew
Journal:  Am J Transplant       Date:  2012-09-07       Impact factor: 8.086

4.  Quality of life and factors predictive of burden among primary caregivers of chronic liver disease patients.

Authors:  Douglas L Nguyen; Daniel Chao; Grace Ma; Timothy Morgan
Journal:  Ann Gastroenterol       Date:  2015 Jan-Mar

5.  Effects of caregiver burden on quality of life and coping strategies utilized by caregivers of adult patients with inflammatory bowel disease.

Authors:  Nimisha K Parekh; Shamita Shah; Kristin McMaster; Alissa Speziale; Laura Yun; Douglas L Nguyen; Gil Melmed; Sunanda Kane
Journal:  Ann Gastroenterol       Date:  2016-09-06

6.  Physical and Mental Quality of Life in Patients With End-Stage Liver Disease and Their Informal Caregivers.

Authors:  Lissi Hansen; Michael F Chang; Christopher S Lee; Shirin Hiatt; Evan J Firsick; Nathan F Dieckmann; Karen S Lyons
Journal:  Clin Gastroenterol Hepatol       Date:  2020-04-11       Impact factor: 11.382

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.